Clarivate Plc Share Price

Equities

CLVT

JE00BJJN4441

Professional Information Services

Market Closed - Nyse 21:00:02 17/07/2024 BST 5-day change 1st Jan Change
6.39 USD +4.07% Intraday chart for Clarivate Plc +16.39% -30.99%
Sales 2024 * 2.61B 201B Sales 2025 * 2.67B 206B Capitalization 4.27B 328B
Net income 2024 * -93M -7.15B Net income 2025 * 14M 1.08B EV / Sales 2024 * 3.48 x
Net Debt 2024 * 4.83B 371B Net Debt 2025 * 4.33B 333B EV / Sales 2025 * 3.22 x
P/E ratio 2024 *
-43 x
P/E ratio 2025 *
407 x
Employees 12,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.2%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.07%
1 week+16.39%
Current month+12.30%
1 month+20.11%
3 months-7.53%
6 months-27.88%
Current year-30.99%
More quotes
1 week
5.64
Extreme 5.64
6.45
1 month
5.32
Extreme 5.32
6.45
Current year
5.19
Extreme 5.19
9.61
1 year
5.19
Extreme 5.19
10.03
3 years
5.19
Extreme 5.19
26.73
5 years
5.19
Extreme 5.19
34.79
10 years
5.19
Extreme 5.19
34.79
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 10/07/22
Director of Finance/CFO 44 15/12/21
Chief Tech/Sci/R&D Officer - 31/01/22
Members of the board TitleAgeSince
Director/Board Member 81 30/04/19
Director/Board Member 63 30/09/16
Director/Board Member 74 06/05/20
More insiders
Date Price Change Volume
17/07/24 6.39 +4.07% 4,577,413
16/07/24 6.14 +6.04% 5,572,833
15/07/24 5.79 0.00% 2,774,166
12/07/24 5.79 +2.48% 4,230,881
11/07/24 5.65 +2.91% 3,970,280

Delayed Quote Nyse, July 17, 2024 at 09:00 pm

More quotes
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It serves a large, diverse, and global customer base across the scientific research, intellectual property, and life sciences and healthcare end markets. Its customers include corporations, universities, law firms, and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6.39 USD
Average target price
7.83 USD
Spread / Average Target
+22.54%
Consensus